Invesco
GBIO

Invesco’s Generation Bio GBIO Stock Holding History

Invesco’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,354
Closed -$5.48K – 3794
2025
Q1 		$5.48K Sell
1,354
-82
-6% -$576 ﹤0.01% 3763
2024
Q4 		$15.2K Buy
1,436
+195
+16% +$3.48K ﹤0.01% 3748
2024
Q3 		$30.7K Sell
1,241
-94
-7% -$2.49K ﹤0.01% 3726
2024
Q2 		$37.7K Sell
1,335
-208
-13% -$6.76K ﹤0.01% 3842
2024
Q1 		$62.8K Sell
1,543
-6,272
-80% -$148K ﹤0.01% 3787
2023
Q4 		$129K Buy
7,815
+374
+5% +$6.52K ﹤0.01% 3652
2023
Q3 		$282K Buy
7,441
+51
+0.7% +$2.42K ﹤0.01% 3474
2023
Q2 		$406K Sell
7,390
-70
-0.9% -$3.21K ﹤0.01% 3355
2023
Q1 		$321K Buy
7,460
+5,792
+347% +$280K ﹤0.01% 3474
2022
Q4 		$65.6K Sell
1,668
-2
-0.1% -$105 ﹤0.01% 3885
2022
Q3 		$89K Buy
1,670
+8
+0.5% +$500 ﹤0.01% 3854
2022
Q2 		$110K Sell
1,662
-256
-13% -$16.7K ﹤0.01% 3870
2022
Q1 		$141K Buy
1,918
+23
+1% +$1.33K ﹤0.01% 3831
2021
Q4 		$135K Sell
1,895
-181
-9% -$31.6K ﹤0.01% 3856
2021
Q3 		$521K Buy
2,076
+307
+17% +$73.5K ﹤0.01% 3411
2021
Q2 		$476K Buy
+1,769
New +$529K ﹤0.01% 3443

Other funds holding GBIO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Invesco's GBIO Position: Q2 2025 in Review

Invesco sold out of Generation Bio (GBIO) in Q2 2025, closing a stake of 1,354 shares — an estimated $5.48K sold.

Invesco first reported a position in GBIO in Q2 2021 and held it in 16 quarters. The position peaked at $521K in Q3 2021. 61 funds tracked by Wall St. Rank hold GBIO as of Q2 2025.

  • Invesco reported no remaining Generation Bio position as of Q2 2025 after selling out during the quarter.
  • Invesco sold 1,354 Generation Bio shares in Q2 2025, an estimated $5.48K.
  • Invesco first reported a position in Generation Bio in Q2 2021 and held it in 16 quarters.
  • Invesco's Generation Bio position peaked at $521K in Q3 2021.
  • 61 funds tracked by Wall St. Rank held Generation Bio as of Q2 2025.

Based on Invesco's 13F filing for Q2 2025, filed 13 Aug 2025.